Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for thetreatment of rare and ultra-rare diseases.
Founded
2010
Raised
$155.1M
Follow us
Alexa global traffic share
Latest funding Show all
$65,000,000
Post-IPO equity - 2016
Takeda Ventures
$75,000,005
Private equity - 2012
Team Size
1–10
Employees
Xconomy

Ultragenyx Sweetens Offer, Dimension Tx Agrees to $151M Acquisition

Health Strategy
$65,000,000 Post-IPO equity
FierceBiotech

Ultragenyx picks up $65M investment, asset in Takeda rare disease R&D pact

Health Deals